Sarcopenia Market Share Projected to Climb to USD 4.23 Billion by 2030

The Sarcopenia Market Share was valued at USD 2.89 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.6% during the forecast period (2023-2030) to reach USD 4.23 billion by 2030. The primary drivers of this growth are the growing geriatric population and the rising incidence rate of muscle degeneration disorders.



Drivers of Growth and Opportunities in the Market

Sarcopenia is loss of muscle mass and/or strength that occurs primarily in the older population, and increases the risk of falling, fracturing and reduced quality of life (QOL) in this group of people. This should be high because aging of global population is exacerbating this condition. The World Health Organization (WHO) forecasts that by 2030, one in six people worldwide will be 60 years or older, highlighting the need for effective interventions against sarcopenia. Market Dynamicsthe increase in awareness among health care professionals and the public resulted in early diagnosis and the market continues to grow as they realise the need for early intervention. 

Discover In-Depth Insights: Get Your Free Sample of Our Latest Report Today @ https://www.maximizemarketresearch.com/request-sample/196035/ 

Segmentation Analysis

The sarcopenia market is segmented into: treatment type, route of administration, distribution channel, and end-user.

Type of Intervention: Interventions included nutritional supplementation with protein, vitamin D, and multivitamins as well as physical therapies comprised of resistance and aerobic exercise. These strategies focus on muscle mass, muscle function, and the interdisciplinary treatment strategy associated with sarcopenia.

Way of Administration: The way the treatment is administered varies, but mostly in the form of oral supplements based on its easy structure for intake. Novel drug formulations may take different routes for maximizing efficacy and tolerability.

by Distribution Channel : Product and services are distrubute through hospital pharmacies, retail pharmacies and online. E-commerce has played a vital role in broadening accessibility, by providing patients with easy access to get their treatments.

by End-User : Major end-users are hospitals, clinics, home care settings. Additionally, with the elderly receiving treatment at home, there has been an increase in demand for portable and easy to administer therapies.

Country-Level Analysis

United States is the largest sarcopenia treatment market as it has a very high aging population. Furthermore, early adoption and diagnosis of the disease with help of advanced healthcare infrastructure is set to boost the early treatment of the disease and thus is driving the market growth.

Germany: One of the stronger economies in Europe — but with a large aging population. The focus on healthcare innovation and preventative measures of the country also supports the growth of innovative sarcopenia therapies and the use of advanced medical systems.

Due to rapid urbanization and increased life expectancy, age-related conditions such as sarcopenia are becoming increasingly common in China. Government initiatives with an emphasis on the elderly and health awareness are likely to increase the market.

Japan has had a super-aged society for some time, and sarcopenia has been recognized as a public health priority for many years. With its cultural focus on health and wellness, as well as innovation and growth in many technology markets, Japan will be a major player.

Brazil: With increasing number of elderly, emerging economies like Brazil are seeing demographic changes. Furthermore, strengthening access to healthcare and the growing awareness of sarcopenia with rising patient population within the territory further aids the growth in the market over the forecast period.

Discover Key Insights: Request a Free Sample of Our Report Today @ https://www.maximizemarketresearch.com/request-sample/196035/ 

Competitive Analysis

The sarcopenia market is highly competitive due to the presence of various pharmaceutical, biotechnology, and academic players engaging in research, product development, and strategic collaborations. Notable companies include:

Biophytis is a clinical stage biotechnology company dedicated to the development of therapies targeting diseases associated with ageing, especially sarcopenia. The U.S. FDA approval in September 2023 to commence the SARA-31 Phase 3 trial represents an important milestone in therapeutic research for sarcopenia.

MyMD Pharmaceuticals, Inc.: MyMD is developing MYMD-1 an oral immune regulator with potential to help extend the years a person can live free of age-related diseases and is a potential option to help manage sarcopenia.

Metagenics LLC–A prominent player in the nutritional supplements market, Metagenics acquired Amipro Advanced Development Products to strengthen its distribution network in South Africa in October 2023.

TNF Pharmaceuticals, Inc.: Involved in sarcopenia research, TNF Pharmaceuticals is identifying new therapeutic ways to treat the deterioration of muscle.

MYOS CORP: Specializing in muscle health, MYOS CORP was awarded a U.S. patent in February 2021 for methods of use for enhancing skeletal muscle protein synthesis, signaling positive advancements in its development of sarcopenia treatments.

Simply Click Here To Buy Full Report @ https://www.maximizemarketresearch.com/checkout/?method=PayPal&reportId=196035&type=Single%20User 

Conclusion

The forecasted growth of the global sarcopenia market to USD 4.23 billion by 2030 indicates that the first steps are being taken to counteract the issues arising with an ageing population. Greater awareness, timely diagnosis, and new treatment strategies, play an important role in tackling sarcopenia. Through the collaborative efforts of researchers, providers, and industry, patient outcomes and quality of life for those living with the condition can be improved.

Explore More: Visit our website for Additional reports:

Bone Hammers Market https://www.maximizemarketresearch.com/market-report/bone-hammers-market/200484/ 

Intraoperative Neurophysiological Monitoring Market https://www.maximizemarketresearch.com/market-report/intraoperative-neurophysiological-monitoring-market/190253/ 

Avascular Necrosis Market https://www.maximizemarketresearch.com/market-report/avascular-necrosis-market/188352/ 

About Maximize Market Research:

Maximize Market Research is a global market research and business consulting firm with offices in India, the USA, and the UAE. Our contribution to revenue and our mission-driven nature of research translates to being one of the proud partners of majority of Fortune 500 companies. Serving all major industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare etc., we have a diversified industry portfolio.

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

⮝ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

✆ +91 9607365656

🖂 sales@maximizemarketresearch.com

🌐 www.maximizemarketresearch.com